Squifflet P, Saad ED, Loibl S, van Mackelenbergh MT, et al. Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Re J Clin Oncol 2023 Mar 28:JCO2202363. doi: 10.1200/JCO.22.02363.
PMID: 36977286